Loading...
Anbio Biotechnology Class A Ordinary Shares
NNNN•NASDAQ
Healthcare
Medical - Instruments & Supplies
$25.28
$-0.19(-0.75%)
U.S. Market is Open • 14:24Anbio Biotechnology Class A Ordinary Shares (NNNN) AI-Powered Stock Analysis
See how Anbio Biotechnology Class A Ordinary Shares scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerAnbio Biotechnology Class A Ordinary Shares (NNNN) Stock Overall Grade
Anbio Biotechnology Class A Ordinary Shares’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Anbio Biotechnology Class A Ordinary Shares's overall stock rating.
Forecast
A+Score
94/100Financial Growth
CScore
40/100Fundamental Growth
AScore
80/100Key Ratios
BScore
67/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
95/100Analyst Consensus
C+Score
50/100Anbio Biotechnology Class A Ordinary Shares (NNNN) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 94/100 (A+), reflecting high confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (80/100, A) highlight its stability, while Key Ratios (67/100, B) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (95/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Anbio Biotechnology Class A Ordinary Shares stock grade, including financials, comparisons, and forecasts.